Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.

NCT07845721 is registered in ClinicalTrials.gov with CooperVision International Limited (CVIL) as lead sponsor.

NCT NCT07845721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07845721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.
Lead sponsor
CooperVision International Limited (CVIL)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
February 29, 2028
Enrollment
58 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myopia